Critical Care Diagnostics Market - Top Companies and Manufacturers

  • Report ID: 5813
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Companies Dominating the Critical Care Diagnostics Landscape

    • Abbott
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • F. Hoffmann-La Roche Ltd
    • Danaher
    • BD
    • EKF Diagnostics
    • bioMérieux, Inc.
    • Siemens Healthcare Private Limited
    • Chembio Diagnostics, Inc.
    • Bayer AG

Browse Key Market Insights with Data Illustration:

In the News

  • Abbott obtained approval from the U.S. Food and Drug Administration (FDA) for the company's industry-leading life support system, CentriMag Blood Pump for use with the CentriMag System a type of life support for people whose heart and lungs are not working, and to enable physicians more time to make critical care decisions for their patients.
  • F. Hoffmann-La Roche Ltd. announced the launch of the next-generation qPCR system, LightCycler PRO System to enable a portfolio of more than 200 LightMix Modular research assays, and to meet clinical needs in molecular diagnostics and tackle public health issues in addition to enabling users to create their tests.

Author Credits:  Radhika Pawar


  • Report ID: 5813
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of critical care diagnostics is estimated at USD 1.44 billion.

The critical care diagnostics market size was over USD 1.38 billion in 2024 and is anticipated to cross USD 2.7 billion by 2037, witnessing more than 5.3% CAGR during the forecast period i.e., between 2025-2037. The growing burden of cancer across the globe and the growing development of quick diagnostic tools will boost the market growth.

North America industry is predicted to hold largest revenue share of 45% by 2037, impelled by growing investment in healthcare in the region.

The major players in the market are F. Hoffmann-La Roche Ltd, Danaher, BD, EKF Diagnostics, bioMérieux, Inc., Siemens Healthcare Private Limited, Chembio Diagnostics, Inc., Bayer AG, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample